TOMBERLI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 1.702
EU - Europa 1.284
AS - Asia 1.033
SA - Sud America 86
AF - Africa 23
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.137
Nazione #
US - Stati Uniti d'America 1.669
RU - Federazione Russa 527
SG - Singapore 321
IT - Italia 294
CN - Cina 285
HK - Hong Kong 102
VN - Vietnam 84
IE - Irlanda 82
PL - Polonia 82
KR - Corea 78
SE - Svezia 71
DE - Germania 67
BR - Brasile 66
IN - India 43
BD - Bangladesh 38
FR - Francia 36
FI - Finlandia 34
GB - Regno Unito 31
JO - Giordania 23
CA - Canada 18
CH - Svizzera 15
NL - Olanda 13
ID - Indonesia 12
MX - Messico 12
JP - Giappone 11
AR - Argentina 10
IQ - Iraq 9
AU - Australia 8
ES - Italia 6
PH - Filippine 6
TR - Turchia 6
AT - Austria 5
NG - Nigeria 5
RS - Serbia 5
ZA - Sudafrica 5
MA - Marocco 4
UA - Ucraina 4
CI - Costa d'Avorio 3
EC - Ecuador 3
PK - Pakistan 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
LT - Lituania 2
NP - Nepal 2
AG - Antigua e Barbuda 1
AL - Albania 1
BJ - Benin 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NA - Namibia 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.137
Città #
Santa Clara 405
Ashburn 262
Singapore 235
San Jose 106
Hong Kong 85
Dublin 82
Seoul 78
Chandler 77
Warsaw 77
Fairfield 70
Hefei 70
Dallas 57
Milan 55
Beijing 50
Moscow 42
New York 42
Florence 40
Munich 39
Houston 33
Seattle 33
Buffalo 31
Cambridge 30
Woodbridge 30
Los Angeles 28
Wilmington 26
Lawrence 24
Ho Chi Minh City 23
Mumbai 23
Altamura 21
Helsinki 21
Hanoi 17
Lauterbourg 17
Rome 17
Princeton 15
Shanghai 15
The Dalles 15
Bern 14
Kent 14
Frankfurt am Main 13
Naples 13
Boston 12
Jakarta 12
Council Bluffs 11
Tokyo 10
Turku 10
Figino 9
Prato 9
Dong Ket 8
Melbourne 8
Boardman 7
Chennai 7
Medford 7
Ann Arbor 6
Atlanta 6
Chicago 6
Paris 6
San Diego 6
Arrone 5
Belgrade 5
Denver 5
Johannesburg 5
London 5
Orem 5
Phoenix 5
Poplar 5
Siena 5
São Paulo 5
Toronto 5
Abuja 4
Amsterdam 4
Baghdad 4
Honolulu 4
Montreal 4
Redondo Beach 4
Turin 4
Vancouver 4
Vienna 4
Abidjan 3
Ankara 3
Augusta 3
Belo Horizonte 3
Bengaluru 3
Bologna 3
City of London 3
Clifton 3
Columbus 3
Da Nang 3
Guangzhou 3
Hillsboro 3
Lappeenranta 3
Manchester 3
Mexico City 3
Miano 3
Ninh Bình 3
Nuremberg 3
Providence 3
Quezon City 3
Rio de Janeiro 3
Salt Lake City 3
Shenzhen 3
Totale 2.645
Nome #
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 273
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 220
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 191
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 191
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 188
Doctor-patient care relationship in genetic cardiomyopathies: An exploratory study on clinical consultations 188
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 186
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 184
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 178
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 177
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome 171
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 169
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy 169
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study 169
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 168
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 162
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 162
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 156
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 154
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 139
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 132
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 132
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 128
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 120
Transition of Cardiovascular Care in Survivors of Pediatric Cancer: From Preventive Strategies to Cardiac Follow-Up's Organization 55
Yield of Genetic Testing in Pediatric Cardiomyopathies: Implications for Novel Therapeutic Options 18
Totale 4.180
Categoria #
all - tutte 12.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022122 5 1 7 3 4 15 4 4 17 10 25 27
2022/2023399 27 85 18 24 26 57 57 22 42 10 13 18
2023/2024255 8 23 24 11 14 41 19 61 8 24 14 8
2024/20251.341 60 135 78 225 357 156 26 59 66 38 64 77
2025/20261.694 174 208 195 143 184 64 210 61 111 128 76 140
2026/202715 15 0 0 0 0 0 0 0 0 0 0 0
Totale 4.180